120 related articles for article (PubMed ID: 1993943)
1. Clinical and immunologic responses to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants injected at 3, 5, 7, and 18 months of age.
Parke JC; Schneerson R; Reimer C; Black C; Welfare S; Bryla D; Levi L; Pavliakova D; Cramton T; Schulz D
J Pediatr; 1991 Feb; 118(2):184-90. PubMed ID: 1993943
[TBL] [Abstract][Full Text] [Related]
2. Persistence of serum antibodies elicited by Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infants vaccinated at 3, 5 and 12 months of age.
Claesson BA; Schneerson R; Lagergård T; Trollfors B; Taranger J; Johansson J; Bryla D; Robbins JB
Pediatr Infect Dis J; 1991 Aug; 10(8):560-4. PubMed ID: 1891286
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants.
Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L
Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435
[TBL] [Abstract][Full Text] [Related]
4. Further studies on the immunogenicity of Haemophilus influenzae type b and pneumococcal type 6A polysaccharide-protein conjugates.
Chu C; Schneerson R; Robbins JB; Rastogi SC
Infect Immun; 1983 Apr; 40(1):245-56. PubMed ID: 6601061
[TBL] [Abstract][Full Text] [Related]
5. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
Bernstein HH; Seyferth ER
Vaccine; 2017 Dec; 35(48 Pt B):6707-6711. PubMed ID: 29054729
[TBL] [Abstract][Full Text] [Related]
6. Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates.
Schneerson R; Robbins JB; Chu C; Sutton A; Vann W; Vickers JC; London WT; Curfman B; Hardegree MC; Shiloach J
Infect Immun; 1984 Sep; 45(3):582-91. PubMed ID: 6332076
[TBL] [Abstract][Full Text] [Related]
7. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccine in infants.
Holmes SJ; Fritzell B; Guito KP; Esbenshade JF; Blatter MM; Reisinger KS; Keyserling HL; Rothstein EP; Bernstein HH; Feldman S
Am J Dis Child; 1993 Aug; 147(8):832-6. PubMed ID: 8352217
[TBL] [Abstract][Full Text] [Related]
9. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study.
Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D
Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
[TBL] [Abstract][Full Text] [Related]
11. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants.
Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B
Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939
[TBL] [Abstract][Full Text] [Related]
12. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine.
Kurikka S; Käyhty H; Peltola H; Saarinen L; Eskola J; Mäkelä PH
Pediatrics; 1995 Jun; 95(6):815-22. PubMed ID: 7761204
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
14. Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy.
Kurikka S; Olander RM; Eskola J; Käyhty H
Pediatr Infect Dis J; 1996 Jun; 15(6):530-5. PubMed ID: 8783351
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants.
Marchant CD; Miller JM; Marshall GS; Blatter M; Aris E; Friedland LR; Boutriau D;
Pediatr Infect Dis J; 2010 Jan; 29(1):48-52. PubMed ID: 20035207
[TBL] [Abstract][Full Text] [Related]
16. Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemia.
Sarnaik S; Kaplan J; Schiffman G; Bryla D; Robbins JB; Schneerson R
Pediatr Infect Dis J; 1990 Mar; 9(3):181-6. PubMed ID: 2336298
[TBL] [Abstract][Full Text] [Related]
17. The immunological response of Thai infants to haemophilus influenzae type B polysaccharide-tetanus conjugate vaccine co-administered in the same syringe with locally produced diphtheria-tetanus-pertussis vaccine.
Kerdpanich A; Hutagalung Y; Watanaveeradej V; Bock HL; Steinhoffmd M
J Med Assoc Thai; 2007 Jul; 90(7):1330-6. PubMed ID: 17710973
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children.
Claesson BA; Trollfors B; Lagergard T; Taranger J; Bryla D; Otterman G; Cramton T; Yang Y; Reimer CB; Robbins JB
J Pediatr; 1988 May; 112(5):695-702. PubMed ID: 3361379
[TBL] [Abstract][Full Text] [Related]
19. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
Barbour ML; Booy R; Crook DW; Griffiths H; Chapel HM; Moxon ER; Mayon-White D
Pediatr Infect Dis J; 1993 Jun; 12(6):478-84. PubMed ID: 8345980
[TBL] [Abstract][Full Text] [Related]
20. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
Klein NP; Abu-Elyazeed R; Cornish M; Leonardi ML; Weiner LB; Silas PE; Grogg SE; Varman M; Frenck RW; Cheuvart B; Baine Y; Miller JM; Leyssen M; Mesaros N; Roy-Ghanta S
Vaccine; 2017 Jun; 35(28):3564-3574. PubMed ID: 28536030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
